Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Exploring 3 High Growth Tech Stocks in the US Market

In This Article:

The United States market has experienced a 2.9% increase in the last week and is up 11% over the past year, with earnings projected to grow by 14% annually in the coming years. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation, robust revenue growth, and adaptability to evolving technological trends.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

20.44%

29.79%

★★★★★★

TG Therapeutics

26.18%

37.61%

★★★★★★

Travere Therapeutics

28.43%

65.01%

★★★★★★

AVITA Medical

27.74%

55.36%

★★★★★★

TKO Group Holdings

22.48%

25.17%

★★★★★★

Alvotech

31.17%

100.18%

★★★★★★

Clene

60.86%

63.07%

★★★★★★

Alnylam Pharmaceuticals

22.76%

58.40%

★★★★★★

Lumentum Holdings

21.55%

119.67%

★★★★★★

Ascendis Pharma

32.36%

59.79%

★★★★★★

Click here to see the full list of 237 stocks from our US High Growth Tech and AI Stocks screener.

Here's a peek at a few of the choices from the screener.

Arcutis Biotherapeutics

Simply Wall St Growth Rating: ★★★★★☆

Overview: Arcutis Biotherapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing treatments for dermatological diseases, with a market cap of $2.05 billion.

Operations: Arcutis Biotherapeutics focuses on the development and commercialization of dermatological treatments, generating $196.54 million in revenue from its pharmaceuticals segment.

Arcutis Biotherapeutics has demonstrated a robust trajectory in addressing atopic dermatitis with its recent Health Canada approval for ZORYVE® cream, marking a significant advancement in steroid-free treatments. The company's strategic focus on dermatological conditions is underscored by a 230% increase in annual revenue to $196.54 million and a reduced net loss from $262.14 million to $140.04 million year-over-year, reflecting effective management and promising market acceptance. With R&D expenses aligning closely with these innovative pursuits, Arcutis is positioning itself as a key player in specialized healthcare solutions, leveraging clinical successes to potentially secure long-term growth and profitability within this niche market.

NasdaqGS:ARQT Revenue and Expenses Breakdown as at Mar 2025
NasdaqGS:ARQT Revenue and Expenses Breakdown as at Mar 2025

IREN

Simply Wall St Growth Rating: ★★★★★☆

Overview: IREN Limited owns and operates bitcoin mining data centers, with a market capitalization of approximately $1.68 billion.


Waiting for permission
Allow microphone access to enable voice search

Try again.